Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2014
  • Online publication date: June 2014

Chapter 22 - Consequences of cerebral small vessel disease: disability, mortality, and prognosis

from Section 3 - Clinical aspects of cerebral small vessel disease


1. World Health Organization. International Classification of Impairments, Disabilities and Handicaps. Geneva: World Health Organization; 1980.
2. World Health Organization. International Classification of Functioning, Disability and Health. Geneva: World Health Organization; 2001. Available from: (accessed January 3, 2014).
3. Katz S. Assessing self-maintenance: Activities of Daily Living, mobility, and Instrumental Activities of Daily Living. J Am Geriatr Soc 1983;31:721–727.
4. Lawton MP, Brody EM. Assessment of older people: self-maintaining and Instrumental Activities of Daily Living. Gerontologist 1969;9:179–186.
5. Gelinàs I, Gauthier L, McIntyre M, et al. Development of a functional measure for persons with Alzheimer’s disease: the Disability Assessment for Dementia. Am J Occup Ther 1999;53:471–481.
6. Van Swieten J, Koudstaal P, Visser M, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
7. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. MD State Med J 1965;14:61–65.
8. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987;149:351–356.
9. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689–701.
10. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review. Stroke 1995;26:1293–1301.
11. Tarvonen-Schröder S, Kurki T, Räihä I, Sourander L. Leukoaraiosis and cause of death: a five year follow up. J Neurol Neurosurg Psychiatry 1995;58:586–589.
12. Inzitari D, Di Carlo A, Mascalchi M, Pracucci G, Amaducci L. The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol 1995;52:687–691.
13. Inzitari D, Cadelo M, Marranci ML, Pracucci G, Pantoni L. Vascular deaths in elderly neurological patients with leukoaraiosis. J Neurol Neurosurg Psychiatry 1997;62:177–181.
14. Briley DP, Haroon S, Sergent SM, Thomas S. Does leukoaraiosis predict morbidity and mortality? Neurology 2000;54:90–94.
15. Inzitari D. Leukoaraiosis: an independent risk factor for stroke? Stroke 2003;34:2067–2071.
16. Pantoni L. Leukoaraiosis: from an ancient term to an actual marker of poor prognosis. Stroke 2008;39:1401–1403.
17. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:3666.
18. Erkinjuntti T, Pantoni L, Scheltens P. Cooperation and networking on white matter disorders: the European Task Force on Age-Related White Matter Changes. Dement Geriatr Cogn Disord 1998;9(Suppl 1):44–45.
19. Pantoni L, Basile AM, Pracucci G, et al. Impact of age-related cerebral white matter changes on the transition to disability – the LADIS study: rationale, design and methodology. Neuroepidemiology 2005;24:51–62.
20. The LADIS Study Group. 2001–2011: a decade of the LADIS (Leukoaraiosis And DISability ) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 2011;32:577–588.
21. Pantoni L, Poggesi A, Basile AM, et al. LADIS Study Group. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis And DISability in the elderly) study. J Am Geriatr Soc 2006;54:1095–2101.
22. Inzitari D, Simoni M, Pracucci G, et al. LADIS Study Group. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007;167:81–88.
23. Inzitari D, Pracucci G, Poggesi A, et al. LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (Leukoaraiosis And DISability) study cohort. BMJ 2009;339:2477.
24. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol 2003;2:238–245.
25. Fisher CM. Lacunar stroke and infarcts: a review. Neurology 1982;32:871–876.
26. Sacco S, Marini C, Totaro R, et al. A population-based study of the incidence and prognosis of lacunar stroke. Neurology 2006;66:1335–1338.
27. Bejot Y, Catteau A, Caillier M, et al. Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a population-based study. Stroke 2008;39:1945–1951.
28. Staaf G, Lindgren A, Norrving B. Pure motor stroke from presumed lacunar infarct: long-term prognosis for survival and risk of recurrent stroke. Stroke 2001;32:2592–2596.
29. Eriksson S-E, Olsson JE. Survival and recurrent strokes in patients with different subtypes of stroke: a 14-year follow-up study. Cerebrovasc Dis 2001;12:171–180.
30. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521–1526.
31. Samuelsson M, Söderfelt B, Olsson GB. Functional outcome in patients with lacunar infarction. Stroke 1996;27:842–846.
32. De Jong G, Kessels F, Lodder J. Two types of lacunar infarcts. Further arguments from a study on prognosis. Stroke 2002;33:2072–2076.
33. Vermeer S, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurology 2007;6:611–619.
34. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992;23:1434–1438.
35. Yamamoto Y, Akiguchi I, Oiwa K, et al. Twenty-four-hour blood pressure and MRI as predictive factors for different outcomes in patients with lacunar infarct. Stroke 2002;33:297–305.
36. Koga H, Takashima Y, Murakawa R, et al. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals. J Stroke Cerebrovasc Dis 2009;18:32–37.
37. Benisty S, Gouw AA, Porcher R, et al. Location of lacunar infarcts correlates with cognition in a sample of non disabled subjects with age-related white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009;80:478–483.
38. Jacova C, Pearce LA, Costello R, et al. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 2012;72:351–362.
39. Van der Flier WM, Cordonnier C. Microbleeds in vascular dementia: clinical aspects. Exp Gerontol 2012;47:853–857.
40. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer’s disease: innocent observation or key player? Brain 2011;134:335–344.
41. Cordonnier C, Al-Shahi SR, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007;130:1988–2003.
42. Biessels GJ, Zwanenburg JJ, Visser F, Frijns CJ, Luijten PR. Hypertensive cerebral hemorrhage: imaging the leak with 7-T MRI. Neurology 2010;75:572–573.
43. Theysohn JM, Kraff O, Maderwald S, et al. Seven Tesla MRI of microbleeds and white matter lesions as seen in vascular dementia. J Magn Reson Imaging 2011;33:782–791.
44. Lesnik Oberstein SA, van den Boom R, van Buchem MA, et al. Cerebral microbleeds in CADASIL. Neurology 2001;57:1066–1070.
45. Viswanathan A, Guichard JP, Gschwendtner A, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain 2006;129:2375–2383.
46. Viswanathan A, Gschwendtner A, Guichard JP, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology 2007;69:172–179.
47. Henneman WJ, Sluimer JD, Cordonnier C, et al. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 2009;40:492–498.
48. Altmann-Schneider I, Trompet S, de Craen AJ, et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke 2011;42:638–644.
49. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection aGainst Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005;112:1644–1650.
50. Mok VC, Lam WW, Fan YH, et al. Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol 2009;256:750–757.
51. Ten Dam VH, van den Heuvel DM, van Buchem MA, et al. for the PROSPER Study Group. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005;64:1807–1809.